Get started
Author

Heinrich Achenbach

Observed names: Achenbach, H., Achenbach, Heinrich, H Achenbach, H. Achenbach
Observed institutions: Merck KGaA, Darmstadt (Germany), Heidelberg University, Takeda (Switzerland), Takeda (United States), Chirurgische Universitätsklinik Heidelberg, Shire (Switzerland)
ORCID: 0000-0002-0110-4122
Observed ORCID: 0000-0002-0110-4122
OpenAlex ID: A5019800434
Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study
2017 · Gunnar Birgegård, Carlos Besses, et al. · Haematologica · 74
PDF
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
2017 · Anna G Nilsson, Ragnhildur Bergthorsdottir, et al. · European Journal of Endocrinology · 39
PDF
Prucalopride induces high‐amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study
2016 · P. B. Miner, M. Camilleri, et al. · Neurogastroenterology & Motility · 32
PDF
Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study
2018 · Gunnar Birgegård, Folke Folkvaljon, et al. · Leukemia Research · 21
PDF
Evaluation of the pharmacokinetics of dalteparin in patients with renal insufficiency
2006 · J. Stöbe, A. Siegemund, et al. · International Journal of Clinical Pharmacology and Therapeutics · 19
Phase III, single-arm study investigating the efficacy, safety, and tolerability of anagrelide as a second-line treatment in high-risk Japanese patients with essential thrombocythemia
2014 · Yuzuru Kanakura, Yoshitaka Miyakawa, et al. · International Journal of Hematology · 18
Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate
2018 · Alastair Hutchison, Andrew Whelton, et al. · ˜The œNephron journals/Nephron journals · 15
Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers
2001 · M. Krueger, H. Achenbach, et al. · International Journal of Clinical Pharmacology and Therapeutics · 11
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study
2015 · Alessandro M Vannucchi, Nicola Cascavilla, et al. · Drug Design Development and Therapy · 9
PDF
Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia
2020 · Mirjana Gotic, Miklos Egyed, et al. · Cardiovascular Toxicology · 7
PDF
A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia
2018 · Yuzuru Kanakura, Yukari Shirasugi, et al. · International Journal of Hematology · 7
Treatment of Essential Thrombocythemia in Europe: An Observational Study of 3649 High-Risk Patients in Exels
2014 · Gunnar Birgegard, Carlos Besses, et al. · Blood · 7
Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
2023 · Carmen Cuffari, William Spalding, et al. · Contemporary Clinical Trials Communications · 6
An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis
2022 · Anna Wasilewska, Rose Ann Murray, et al. · BMC Nephrology · 3
PDF
Sa1719 EVALUATION OF MAJOR ADVERSE CARDIAC EVENTS FROM CLINICAL STUDIES OF PRUCALOPRIDE IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION
2020 · Jimmy Hinson, Heinrich Achenbach, et al. · Gastroenterology · 3
Effects of treatment cessation and re‐treatment in randomized controlled trials of prucalopride in patients with chronic idiopathic constipation
2023 · Jimmy Hinson, Heinrich Achenbach, et al. · Neurogastroenterology & Motility · 2
PDF
Effect of anagrelide on cardiac repolarization in healthy volunteers: a randomized, double‐blind, placebo‐ and positive‐controlled, thorough QT study
2014 · Steven Troy, Virginia Parks, et al. · Pharmacology Research & Perspectives · 2
PDF
Blood Use Reduction by Predonation — How Effective is It?
1991 · H. Achenbach, A. Tanzeem, et al. · Steinkopff eBooks · 2
Corrigendum to “Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation” [Contemp. Clin. Trials Commun. 33 (2023) 101144]
2024 · Carmen Cuffari, William Spalding, et al. · Contemporary Clinical Trials Communications · 1
Risk Factors for Thrombohemorrhagic and Transformation Events in 3649 High-risk Patients With Essential Thrombocythemia : Results From the Prospective Long-term Observational Exels Study
2015 · Gunnar Birgegård, Carlos Besses, et al. · Haematologica · 1
[Experimental kidney hypertrophy after unilateral nephrectomy in rats. Studies with thymidine- H3].
1965 · H Noltenius, H Achenbach, et al. · PubMed · 1
S0505 The Effect of Retreatment and Treatment Cessation in Clinical Studies of Prucalopride in Patients With Chronic Idiopathic Constipation
2020 · Jimmy Hinson, Heinrich Achenbach, et al. · The American Journal of Gastroenterology
Supplementary Material for: Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate
2018 · Hutchison, A., Whelton, A., et al. · Figshare
Sp347mortality and Bone Safety Outcomes in Patients With End-stage Renal Disease Receiving Lanthanum Carbonate: a Long-term, Observational Study
2017 · Alastair Hutchison, Ravi Thadhani, et al. · Nephrology Dialysis Transplantation
PDF
A Phase 3b, open-label, extension study to evaluate the long-term safety of once-daily, dual-release hydrocortisone (DR-HC) in patients with adrenal insufficiency (AI)
2016 · Anna Nilsson, Ragnhildur Bergthorsdottir, et al. · Endocrine Abstracts
PDF
Works count: 38
Citation count: 279
H-index: 9
I10-index: 8
Year
Topic
Type